IECM
TNDM icon

Intrinsic Edge Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Intrinsic Edge Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-247,391
Closed -$11.8M – 180
2022
Q3 		$11.8M Buy
247,391
+3,966
+2% +$217K 1.29% 26
2022
Q2 		$14.4M Buy
243,425
+111,250
+84% +$9.13M 1.12% 20
2022
Q1 		$15.4M Buy
132,175
+5,244
+4% +$612K 1.18% 23
2021
Q4 		$19.1M Buy
126,931
+58,989
+87% +$7.96M 1.22% 17
2021
Q3 		$8.11M Sell
67,942
-133,593
-66% -$14.7M 0.56% 67
2021
Q2 		$19.6M Buy
201,535
+19,135
+10% +$1.71M 1.15% 11
2021
Q1 		$16.1M Sell
182,400
-34,930
-16% -$3.25M 1.1% 16
2020
Q4 		$20.8M Buy
217,330
+160,334
+281% +$16.5M 1.54% 10
2020
Q3 		$6.47M Sell
56,996
-24,397
-30% -$2.56M 0.44% 89
2020
Q2 		$8.05M Sell
81,393
-58,693
-42% -$4.68M 0.74% 38
2020
Q1 		$9.02M Buy
+140,086
New +$9.82M 1.19% 23

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Intrinsic Edge Capital Management's TNDM Position: Q4 2022 in Review

Intrinsic Edge Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 247,391 shares — an estimated $11.8M sold.

Intrinsic Edge Capital Management first reported a position in TNDM in Q1 2020 and held it in 11 quarters. The position peaked at $20.8M in Q4 2020. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Intrinsic Edge Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 247,391 Tandem Diabetes Care shares in Q4 2022, an estimated $11.8M.
  • Intrinsic Edge Capital Management first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 11 quarters.
  • Intrinsic Edge Capital Management's Tandem Diabetes Care position peaked at $20.8M in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.